Wade Walke | VP, IR |
Stanley Crooke | Founder, Chairman, CEO & President |
Elizabeth Hougen | SVP, Finance & CFO |
Brett Monia | Founder, COO, SVP, Translational Medicine & Director |
Frank Bennett | SVP, Antisense Research |
Chad Messer | Needham & Company |
Benjamin Burnett | Stifel, Nicolaus & Company |
Rick Bienkowski | SVB Leerink |
David Lebowitz | Morgan Stanley |
Yanan Zhu | Wells Fargo Securities |
Ritu Baral | Cowen and Company |
Eliana Merle | Cantor Fitzgerald & Co. |
Jessica Fye | JPMorgan Chase & Co. |
I-Eh Jen | Laidlaw & Company |
Good morning and welcome to the Ionis Pharmaceuticals Q1 2019 Financial Results Conference Call.
As a reminder, this call is being recorded. At this time, I would like to turn the call over to Wade Walke, Vice President, Investor Relations, to lead off the call. Please begin.
Thank you, Gary.